Reference
Moodley M. LEMTRADA (alemtuzumab): Restricted indication, additional contraindications and risk minimisation measures. Internet Document : [3 pages], 28 Jan 2020. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information-lemtrada
Rights and permissions
About this article
Cite this article
New restrictions for alemtuzumab due to risk of serious ADRs. Reactions Weekly 1791, 1 (2020). https://doi.org/10.1007/s40278-020-74846-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74846-6